HKSE - Delayed Quote HKD
ASCLETIS-B (1672.HK)
6.120
-0.490
(-7.41%)
As of 9:30:44 AM GMT+8. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 731.97M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Wu (Hejingdao Judy) Director (Executive) | -- | Direct | -- | Jan 12, 2024 |
| Wu (Jinzi Jason) Chief Executive Officer | -- | Direct | -- | Jan 12, 2024 |
Related Tickers
2616.HK CStone Pharmaceuticals
2.450
-10.58%
1530.HK 3SBIO
11.100
-8.11%
145020.KQ Hugel, Inc.
351,500.00
-1.68%
1541.HK IMMUNEONCO-B
5.900
-8.39%
6996.HK Antengene Corporation Limited
2.870
-0.69%
2171.HK CARsgen Therapeutics Holdings Limited
16.340
-3.20%
2142.HK HBM Holdings Limited
8.410
-6.45%
1548.HK GENSCRIPT BIO
10.580
-3.11%
9688.HK Zai Lab Limited
21.750
-7.84%
IFRX InflaRx N.V.
1.6100
+1.90%